InsightRX, based in San Francisco, has developed a cloud-based platform for precision medicine.
The technology underlying the InsightRX platform incorporates the principles of quantitative pharmacology and machine learning to provide a detailed understanding of a patient’s response to treatment.
The insightRX platform supports treatment decisions at both the individual level and population level, with an initial focus on improving dose selection for drugs that have a narrow therapeutic window.
The company has commercial partnerships with global leaders in the precision medicine space, including UCSF, Stanford and Genentech.
The vision of the company is to apply their technology to continuously improve treatment decisions across a variety of drugs and indications.